Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AVDL's stock price target?
Not Available
AVDL doesn't have any price targets made by Wall Street professionals.
What is Avadel Pharmaceuticals PLC's Revenue forecast?
Projected CAGR
31%
For the last 13 years the
compound annual growth rate for
Avadel Pharmaceuticals PLC's revenue is
14%.
The projected
CAGR
for the next 4 years is
31%.